President and CEO, Yvonne Wang Provides Shareholders with an Update on Marketing Strategy and Revenue Focus for 2019
Yangling, Shaanxi— January 9, 2019 — Ms. Yvonne Wang, President & Chief Executive Officer of Kiwa Bio-Tech Products Group Corp. (“Kiwa” or the “Company”) (OTCQB: KWBT) has issued an important letter to shareholders.
Dear Kiwa Bio-Tech Products Group Corporation Shareholder,
It is a distinct pleasure to have the opportunity to communicate with you through this letter to share the company’s milestones to date and provide you with insight regarding our plans for growth in 2019 as we expand the overall company with a clear focus on increasing shareholder value.
Kiwa is ideally positioned to benefit from the rapidly changing agricultural market environments in China. The Government in China continues to support improved strategies and advanced microbial fertilizers for use throughout the agricultural sector. In June 2018, the Ministry of Agriculture and Rural Affairs of China and the Ministry of Finance of China provided further promotion of green agriculture, including policy and financial support. In addition, in January 1, 2019, China Officially Promulgated The First Soil Contamination Prevention Law Of PRC.
The Government of China is currently providing significant financial support and is vigorously promoting the integration of farming and breeding programs in rural areas, aiming to further develop green agriculture, restore the farmland and alleviate rural poverty by focusing on utilizing the wastes of breeding and planting industry.
Kiwa Bio-Tech is currently in a lead position to provide eco-friendly planting techniques and fertilizer utilization methods, which will contribute to the development of the program. Kiwa also anticipates enhancing local farmers’ income. The company has received approval from the Yangling Free Trade Zone in China to obtain land for the construction of a manufacturing facility to meet the US$16 billion-dollar growing demand for bio-fertilizers in China over the next 5 years.
The manufacturing facility will specialize in developing and producing Kiwa Bio-Tech’s core microbes, the fundamental components for making high-quality bio-fertilizers. The facility will have a production capacity of 60,000 tons of Kiwa Bio-Tech’s core microbes with an annual production value estimated to be over US$65 million dollars (approximately 462 million RMB).
In 2019, the Company strategy will be focused upon increasing annual sales by establishing financing and insurance options for farmers throughout each province. Our goal is to have Kiwa brand presence in all of China’s provinces. Our marketing strategy is designed to open new markets with the help of local government and their strong agricultural initiatives.
In Yangling, China alone, there are over 300 planting bases covering approximately 4.4 million hectares of farmlands in Yangling, which will demand over $3.6 billion USD chemical fertilizers and $7.8 billion USD microbial fertilizers every year. Kiwa Bio-Tech will significantly tap this fertilizer market in the next several years.
Kiwa Bio-Tech is establishing the eco-friendly agricultural manufacturing base and operational headquarters in Yangling Free Trade Zone;
Kiwa Bio-Tech positioned to play a key role in China’s growing fruit industry;
Kiwa Bio-Tech receives approval from the Yangling Free Trade Zone to obtain land for construction of manufacturing facility;
Kiwa Bio-Tech announces record third quarter 2018 financial results and growth plans in place for strong 2019;
Kiwa Bio-Tech announces the formal implementation of the Trinity Agricultural Marketing Model in Zhouzhi County, China;
Kiwa Bio-Tech announces signed strategic agreement with the Professional Farmers Association Of Zhouzhi County on theimplementation of the Trinity Agricultural Marketing Model;
Kiwa Bio-Tech receives strong government interest for its soil remediation technology at CAF;
Kiwa Bio-Tech announces establish of first Research and Development Institute in China;
Kiwa Bio-Techhas appointed Dr. Yanan Tong as the first dean of the Kiwa R & D Instutite.;
Kiwa Bio-Tech appointed Vice Chairman of China Association of Enterprises with Foreign Investment (“CAEFI”).
Kiwa’s Business Outlook
Kiwa’s Eco-friendly Agricultural Innovation Model——1+2 Model “Trinity” received an official letter from the Yangling government regarding implementation of Kiwa’s Complete Agricultural Innovation model to a national-level Yangling model, and copy and promote it in Yangling’s demonstration planting bases.
The 54 standard specifications for planting of major crops edited by Kiwa’s Research Institute have also been promoted to the national agricultural planting areas by the Yangling Demonstration Zone as the standard system for scientific planting and standardization management throughout China.
The Company is continually striving to establish a standardized eco-friendly agricultural industry chain in China.
Thank you for your interest and investment in Kiwa and please contact us with any questions,
About Kiwa Bio-Tech Products Group Corp.
Leader in Eco-friendly Agricultural Industry Chain
Kiwa Bio-Tech Products Group Corp. (KWBT) is a publicly traded company with corporate headquarters in the Yangling, Shaanxi, China. The company develops, manufacture, markets and distributes innovative and environmentally safe bio-technological products for agriculture. Kiwa’s focus is to positively impact the environment by reducing the amount of chemical fertilizers that are being used by agricultural growers in China.
Kiwa Bio-Tech Products Group Corp. products are covered by patent protection and are designed to enhance the quality of human life by increasing the value and productivity of agricultural crops.
For more information on Kiwa Bio-Tech Products Group Corp. or its bio-fertilizer products and smart soil remediation technology, please refer to the Company’s website at www.kiwabiotech.com or the Company filings with the United States Securities and Exchange Commission at www.sec.gov.
This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company’s reports filed with the U.S. Securities and Exchange Commission. The forward-looking information provided herein represents the Company’s estimates as of the date of the press release, and subsequent events and developments may cause the Company’s estimates to change. The Company’s actual results may differ materially from those anticipated in the forward-looking statements depending on a number of risk factors including, but not limited to, the following: general economic, business and environment conditions, development, shipment, market acceptance, additional competition from existing and new competitors, changes in technology, the execution of its ten-year growth plan, the foreign exchange risk amid the unexpected announcements by the PRC government and various other factors beyond the Company’s control. Kiwa Bio-Tech Products Group Corp. specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company’s estimates of its future financial performance as of any date subsequent to the date of this press release.